Tumor necrosis factor: Biology and therapeutic inhibitors

This publication has 76 references indexed in Scilit:

• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
  Gut, 1999
• Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
  Published by Elsevier ,1999
• Role of NF-κB in immune and inflammatory responses in the gut
  Gut, 1998
• TNF-α Induction of CD44-Mediated Leukocyte Adhesion by Sulfation
  Science, 1998
• Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
  European Journal of Immunology, 1997
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
  Cell, 1996
• A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
  Journal of Clinical Investigation, 1995
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• The Biology of Cachectin/TNF -- A Primary Mediator of the Host Response
  Annual Review of Immunology, 1989